Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Disease marker combination enhances patient characterization in the Finnish sarcoidosis patients.

Lahtela E, Wolin A, Pietinalho A, Lokki ML, Selroos O.

Respir Med. 2017 Nov;132:92-94. doi: 10.1016/j.rmed.2017.09.014. Epub 2017 Oct 3.

PMID:
29229112
2.

SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations.

Wolin A, Lahtela EL, Anttila V, Petrek M, Grunewald J, van Moorsel CHM, Eklund A, Grutters JC, Kolek V, Mrazek F, Kishore A, Padyukov L, Pietinalho A, Ronninger M, Seppänen M, Selroos O, Lokki ML.

Front Immunol. 2017 Apr 19;8:422. doi: 10.3389/fimmu.2017.00422. eCollection 2017.

3.

No change in prevalence of symptoms of COPD between 1996 and 2006 in Finnish adults - a report from the FinEsS Helsinki Study.

Kainu A, Pallasaho P, Pietinalho A.

Eur Clin Respir J. 2016 Aug 16;3:31780. doi: 10.3402/ecrj.v3.31780. eCollection 2016.

4.

Proteomic changes of alveolar lining fluid in illnesses associated with exposure to inhaled non-infectious microbial particles.

Teirilä L, Karvala K, Ahonen N, Riska H, Pietinalho A, Tuominen P, Piirilä P, Puustinen A, Wolff H.

PLoS One. 2014 Jul 17;9(7):e102624. doi: 10.1371/journal.pone.0102624. eCollection 2014.

5.

Major histocompatibility complex class II and BTNL2 associations in sarcoidosis.

Wennerström A, Pietinalho A, Lasota J, Salli K, Surakka I, Seppänen M, Selroos O, Lokki ML.

Eur Respir J. 2013 Aug;42(2):550-3. doi: 10.1183/09031936.00035213. No abstract available.

6.

Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study.

Kainu A, Pallasaho P, Piirilä P, Lindqvist A, Sovijärvi A, Pietinalho A.

Prim Care Respir J. 2013 Mar;22(1):64-71. doi: 10.4104/pcrj.2013.00002.

7.

HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis.

Wennerström A, Pietinalho A, Vauhkonen H, Lahtela L, Palikhe A, Hedman J, Purokivi M, Varkki E, Seppänen M, Lokki ML, Selroos O; Finnish Sarcoidosis Study Group.

Hum Immunol. 2012 Jan;73(1):93-100. doi: 10.1016/j.humimm.2011.10.016. Epub 2011 Oct 23.

PMID:
22074998
8.

Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme.

Vasankari T, Pietinalho A, Lertola K, Junnila SY, Liippo K.

BMC Fam Pract. 2011 Sep 21;12:97. doi: 10.1186/1471-2296-12-97.

9.

The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality.

Kinnula VL, Vasankari T, Kontula E, Sovijarvi A, Saynajakangas O, Pietinalho A.

Prim Care Respir J. 2011 Jun;20(2):178-83. doi: 10.4104/pcrj.2011.00024.

10.

Linkage between smoking and asthma.

Pietinalho A, Pelkonen A, Rytilä P.

Allergy. 2009 Dec;64(12):1722-7. doi: 10.1111/j.1398-9995.2009.02208.x. Epub 2009 Oct 12. Review.

PMID:
19832738
11.

Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.

von Hertzen LC, Savolainen J, Hannuksela M, Klaukka T, Lauerma A, Mäkelä MJ, Pekkanen J, Pietinalho A, Vaarala O, Valovirta E, Vartiainen E, Haahtela T.

Allergy. 2009 May;64(5):678-701. doi: 10.1111/j.1398-9995.2009.02024.x. Review.

PMID:
19383025
12.

Kyhmyruusu (erythema nodosum).

Pietinalho A.

Duodecim. 2007;123(4):397. Finnish. No abstract available.

PMID:
17405703
13.

Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report.

Pietinalho A, Kinnula VL, Sovijärvi AR, Vilkman S, Säynäjäkangas O, Liippo K, Kontula E, Laitinen LA.

Respir Med. 2007 Jul;101(7):1419-25. Epub 2007 Mar 13.

14.

Sarkoidoosi.

Pietinalho A.

Duodecim. 2006;122(17):2101-10. Finnish. No abstract available.

PMID:
17115627
15.

A 10 year asthma programme in Finland: major change for the better.

Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA.

Thorax. 2006 Aug;61(8):663-70.

16.
17.

Studies of cytokine levels in bronchoalveolar fluid lavage from patients with interstitial lung diseases.

Wolff H, Teppo AM, Mutanen P, Sutinen S, Backman R, Sutinen S, Pietinalho A, Riska H.

Scand J Clin Lab Invest. 2003;63(1):27-36.

PMID:
12729067
18.

Sleep apnoea: Finnish National guidelines for prevention and treatment 2002-2012.

Laitinen LA, Anttalainen U, Pietinalho A, Hämäläinen P, Koskela K; Expert Advisory Group Listed in Foreword.

Respir Med. 2003 Apr;97(4):337-65.

19.

Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma.

Ind PW, Villasante C, Shiner RJ, Pietinalho A, Böszörményi NG, Soliman S, Selroos O.

Eur Respir J. 2002 Oct;20(4):859-66.

20.

The quality of spirometric examinations in Finland: results from a national questionnaire survey.

Piirilä P, Pietinalho A, Loponen M, Naumanen H, Nurminen M, Siukola A, Korhonen O, Koskela K, Sovijärvi A.

Clin Physiol Funct Imaging. 2002 May;22(3):233-9.

PMID:
12076352
21.

Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.

Verleden GM, du Bois RM, Bouros D, Drent M, Millar A, Müller-Quernheim J, Semenzato G, Johnson S, Sourvino G, Olivier D, Pietinalho A, Xaubet A.

Eur Respir J Suppl. 2001 Sep;32:17s-29s. Review.

22.

Early treatment of stage II sarcoidosis improves 5-year pulmonary function.

Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O; Finnish Pulmonary Sarcoidosis Study Group.

Chest. 2002 Jan;121(1):24-31.

PMID:
11796428
23.

The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases.

Pietinalho A, Ohmichi M, Löfroos AB, Hiraga Y, Selroos O.

Sarcoidosis Vasc Diffuse Lung Dis. 2000 Jun;17(2):158-66.

PMID:
10957764
24.

Familial sarcoidosis in Finland and Hokkaido, Japan--a comparative study.

Pietinalho A, Ohmichi M, Hirasawa M, Hiraga Y, Löfroos AB, Selroos O.

Respir Med. 1999 Jun;93(6):408-12.

26.

The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients.

Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O.

Eur Respir J. 1999 Apr;13(4):723-6.

27.

Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients.

Tötterman KJ, Huhti L, Sutinen E, Backman R, Pietinalho A, Falck M, Larsson P, Selroos O.

Eur Respir J. 1998 Sep;12(3):573-9.

28.

The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.

Seppälä OP, Herrala J, Hedman J, Alanko K, Liipo K, Terho E, Pietinalho A, Nyholm JE, Nieminen MM.

Respir Med. 1998 Mar;92(3):578-83.

29.

The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients.

Pietinalho A, Ohmichi M, Hiraga Y, Löfroos AB, Selroos O.

Sarcoidosis Vasc Diffuse Lung Dis. 1996 Sep;13(2):159-66.

PMID:
8893386
30.

Inhaled corticosteroids and pulmonary sarcoidosis.

Pietinalho A, Selroos O.

Eur Respir J. 1996 Jan;9(1):180-1. No abstract available.

31.

Effect of early vs late intervention with inhaled corticosteroids in asthma.

Selroos O, Pietinalho A, Löfroos AB, Riska H.

Chest. 1995 Nov;108(5):1228-34.

PMID:
7587421
32.

The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study.

Pietinalho A, Hiraga Y, Hosoda Y, Löfroos AB, Yamaguchi M, Selroos O.

Sarcoidosis. 1995 Mar;12(1):61-7.

PMID:
7617979
34.

Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler.

Selroos O, Backman R, Forsén KO, Löfroos AB, Niemistö M, Pietinalho A, Aikäs C, Riska H.

Allergy. 1994 Dec;49(10):888-90.

PMID:
7710001
35.

Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients.

Selroos O, Backman R, Forsén KO, Löfroos AB, Niemistö M, Pietinalho A, Riska H.

Allergy. 1994 Dec;49(10):833-6.

PMID:
7709992
36.

Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.

Selroos O, Löfroos AB, Pietinalho A, Niemistö M, Riska H.

Sarcoidosis. 1994 Sep;11(2):126-31.

PMID:
7809497
37.

Sarcoidosis in the Nordic countries 1950-1987.

Forsén KO, Milman N, Pietinalho A, Selroos O.

Sarcoidosis. 1992 Sep;9(2):140-1. No abstract available.

PMID:
1344057
38.

Inhaled corticosteroid therapy in pulmonary sarcoidosis.

Pietinalho A.

Sarcoidosis. 1991 Sep;8(2):168-9. No abstract available.

PMID:
1669984

Supplemental Content

Loading ...
Support Center